Generation of X-CGD cells for vector evaluation from healthy donor CD34(+) HSCs by shRNA-mediated knock down of gp91(phox)

Innovative approaches for the treatment of rare inherited diseases are hampered by limited availability of patient derived samples for preclinical research. This also applies for the evaluation of novel vector systems for the gene therapy of monogenic hematological diseases like X-linked chronic gra...

Descripción completa

Detalles Bibliográficos
Autores principales: Brendel, Christian, Kaufmann, Kerstin B, Krattenmacher, Anja, Pahujani, Shweta, Grez, Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4362359/
https://www.ncbi.nlm.nih.gov/pubmed/26015977
http://dx.doi.org/10.1038/mtm.2014.37

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4362359/
https://www.ncbi.nlm.nih.gov/pubmed/26015977
http://dx.doi.org/10.1038/mtm.2014.37

Ejemplares similares